Menu
Search
Home > Courses > Update on HCV Management in People Living with HIV and Other Key Populations

Update on HCV Management in People Living with HIV and Other Key Populations

Update on HCV Management in People Living with HIV and Other Key Populations
Play
Sorry, this learning module is not available for mobile devices.
Original Release Date: 12/11/2018
Termination Date: 12/10/2021
Review Date: 4/8/2019
Presenter
  • Kristen Marks, MD
    Assistant Professor of Medicine
    Weill Cornell Medical College
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Be aware of updated HCV testing recommendations.
  2. Know initial treatment recommendations for PLWH and other key populations.
  3. Appreciate a strategy for initial HCV treatment simplification.
Presenter Bio
Kristen Marks, MD
Dr. Marks is Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at New York Presbyterian Hospital. She received her medical degree from Columbia University, College of Physicians and Surgeons, and is board certified in Internal Medicine and Infectious Diseases. Dr. Marks completed Internal Medicine residency and Infectious Diseases fellowship training at New York-Presbyterian Hospital, where she focused her clinical training and research on HIV and hepatitis virus infections. She also completed Weill Cornell's Master's Degree in Clinical Investigation. Dr. Marks’ research focuses on improving treatment outcomes in patients with HIV and hepatitis virus co-infections and includes studies of acute HCV as well as new treatment strategies for chronic HCV. She was the vice chair of an AIDS Clinical Trials Group (ACTG) multi-center study, currently serves on 3 other ACTG hepatitis protocol teams, and is a member of the ACTG Hepatitis Transformative Science Group. She is co-investigator in the Cornell HIV/AIDS Clinical Trials Unit and Center for Study of Hepatitis C, where she is the site PI for 5 treatment studies and 2 other protocols related to HCV. She also sits on IDSA, AASLD, and IAS-USA’s joint guidelines panel for “Recommendations for testing, managing and treating hepatitis C”.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit on December 11, 2018 and will terminate December 10, 2021.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

 Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Dr. Kristen Marks, MD (Presenter) has had the following personal financial relationships in the past 12 months with manufacturers of the products or services that may be presented in this CME activity: Research support from Gilead and BMS. Dr. Marks submitted her slides in advance for adequate peer review, and will support her presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Gilead Sciences, Janssen Therapeutics (a division of Janssen Products, LP), Merck & Co., and ViiV Healthcare.

Details: 

  • This online video and post-activity evaluation are one hour in length. 
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules